Support of existing NHSBT owned Extracorporeal Photopheresis (ECP) Systems
Contract Value:
GBP 6M -
Notice Type:
Contract Notice
Published Date:
28 June 2024
Closing Date:
03 August 2024
Location(s):
UK UNITED KINGDOM
UKK SOUTH WEST (ENGLAND) (UK UNITED KINGDOM)
Description:
Procurement for maintenance, training, and consumables to support existing Therakos CellEx Extracorporeal Photopheresis machine platforms used by NHSBT TAS teams across England and South Wales.
Support of existing NHSBT owned Extracorporeal Photopheresis (ECP) Systems. The Therapeutic Apheresis Services (TAS) function operates within the Clinical Services directorate of NHSBT. Multi-disciplinary TAS teams operate from eight regional hub units and three 3 spoke sites that are based within Acute NHS Trusts across England and South Wales. Each unit provides a portfolio of therapeutic treatments to both adult and paediatric patients from across a range of clinical specialities. Included in the TAS portfolio of therapeutic procedures is Extracorporeal Photopheresis (ECP) which is provided from four of the TAS hub units (Bristol, London, Oxford, and Manchester) as well as all three of the spoke sites (the Clatterbridge Cancer Centre, Cardiff and The Vale Health Board and Plymouth University Hospitals Trust). The ECP system’s utilised by the TAS teams are able to perform both adult and paediatric procedures and have an integral clinical grade light box. The requirement for this procurement is for maintenance, training and consumables to support existing Therakos CellEx Extracorporeal Photopheresis machine platforms. This Contract is for a period of 2 years with one 12-month option to extend.
The Therapeutic Apheresis Services (TAS) function operates within the Clinical Services directorate of NHSBT. Multi-disciplinary TAS teams operate from eight regional hub units and three 3 spoke sites that are based within Acute NHS Trusts across England and South Wales. Each unit provides a portfolio of therapeutic treatments to both adult and paediatric patients from across a range of clinical specialities. Included in the TAS portfolio of therapeutic procedures is Extracorporeal Photopheresis (ECP) which is provided from four of the TAS hub units (Bristol, London, Oxford, and Manchester) as well as all three of the spoke sites (the Clatterbridge Cancer Centre, Cardiff and The Vale Health Board and Plymouth University Hospitals Trust). The ECP system’s utilised by the TAS teams are able to perform both adult and paediatric procedures and have an integral clinical grade light box. The requirement for this procurement is for maintenance, training and consumables to support existing Therakos CellEx Extracorporeal Photopheresis machine platforms. This Contract is for a period of 2 years with one 12-month option to extend.